Showing results (31-40 of 110) with videos related to
Sort By:
Pageof 11
Intestinal Research|May 15, 2024
What to do when traditional rescue therapies fail in acute severe ulcerative colitisChristopher F D Li Wai Suen, Matthew C Choy, Peter De CruzJGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
Upadacitinib in end stage renal disease: A case of acute severe ulcerative colitisPatrick Hilley, Danny Con, Matthew C Choy, et al.The Journal of Cardiovascular Surgery|September 28, 2022
Frailty predicts poor longer-term outcomes in patients following lower limb open surgical revascularizationAsanish Kalyanasundaram, Matthew Choy, Alekhya Kotta, et al.Inflammatory Bowel Diseases|April 28, 2012
Mucosal healing in Crohn's disease: a systematic reviewPeter De Cruz, Michael A Kamm, Lani Prideaux, et al.Journal of Gastroenterology and Hepatology|January 24, 2023
Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of dosesAshish Srinivasan, Peter De Cruz, Melissa Sam, et al.Scandinavian Journal of Gastroenterology|May 17, 2017
Health care costs associated with Australian tertiary inflammatory bowel disease careBelinda Jackson, Danny Con, Ronald Ma, et al.Inflammatory Bowel Diseases|August 11, 2011
Postoperative recurrent luminal Crohn's disease: a systematic reviewPeter De Cruz, Michael A Kamm, Lani Prideaux, et al.Internal Medicine Journal|April 18, 2018
Examination of the relationship between disease activity and patient-reported outcome measures in an inflammatory bowel disease cohortBelinda D Jackson, Danny Con, Alexandra Gorelik, et al.Inflammatory Bowel Diseases|June 12, 2014
Fecal biomarkers in the diagnosis and monitoring of Crohn's diseaseEmily K Wright, Peter De Cruz, Richard Gearry, et al.Inflammatory Bowel Diseases|February 22, 2011
Practical application of anti-TNF therapy for luminal Crohn's diseaseMichael A Kamm, Siew C Ng, Peter De Cruz, et al.Pageof 11